Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma
Abstract Background Patients with metastatic hepatoblastoma are treated with severely toxic first-line chemotherapies in combination with surgery. Yet, inadequate response of lung metastases to neo-adjuvant chemotherapy still compromises patient outcomes making new treatment strategies, tailored to...
保存先:
| 主要な著者: | , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2024-11-01
|
| シリーズ: | Journal of Experimental & Clinical Cancer Research |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s13046-024-03221-6 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|